Earnings Watch: Bristol-Myers Squibb is Scheduled to Report its Quarterly ... Financial News Network Online The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. By Mallory Stone. |
